Gunel Ayyubova
Baku, BA, Azerbaijan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
P2X7 Signaling in Neuroinflammation: Glial Crosstalk, Redox Integration, and Therapeutic Targeting.
Journal: Journal of molecular neuroscience : MN
Published: June 11, 2026
Mesenchymal Stem Cell Therapy Modulates Peripheral-Central Immune Interactions and Attenuates Neuroinflammation-Driven Cognitive Dysfunction.
Journal: International journal of molecular sciences
Published: January 04, 2026
Roles of Reactive Oxygen Species in Relationships Between Viral Infections and Alzheimer's Disease and Related Dementia.
Journal: Antioxidants (Basel, Switzerland)
Published: December 08, 2025
Microglial NLRP3 Inflammasomes in Alzheimer's Disease Pathogenesis: From Interaction with Autophagy/Mitophagy to Therapeutics.
Journal: Molecular neurobiology
Published: May 15, 2024
Beneficial versus Detrimental Effects of Complement-Microglial Interactions in Alzheimer's Disease.
Journal: Brain sciences
Published: April 04, 2024
The Role of Furin in the Pathogenesis of COVID-19-Associated Neurological Disorders.
Journal: Life (Basel, Switzerland)
Published: January 04, 2024
Extracellular vesicles from hiPSC-NSCs can prevent peripheral inflammation-induced cognitive dysfunction with inflammasome inhibition and improved neurogenesis in the hippocampus.
Journal: Journal of neuroinflammation
Published: June 14, 2023
APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease.
Journal: CNS & neurological disorders drug targets
Published: September 01, 2022
Dysfunctional microglia and tau pathology in Alzheimer's disease.
Journal: Reviews in the neurosciences
Published: July 20, 2022
TREM2 signalling as a multifaceted player in brain homoeostasis and a potential target for Alzheimer's disease treatment.
Journal: The European journal of neuroscience
Published: June 11, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026